James T. Parsons Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

James T. Parsons is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 59,937 shares of DMAC, which is worth approximately $263,722. The most recent transaction as insider was on Jan 02, 2024, when has been sold 21,428 shares (Voting Common Shares, no par value per share) at a price of $2.8 per share, resulting in proceeds of $59,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.9K
0% 3M change
55.64% 12M change
Total Value Held $263,722

James T. Parsons Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
$59,998 $2.8 p/Share
21,428 Added 26.34%
59,937 Voting Common Shares, ...
Jan 03 2022
BUY
Grant, award, or other acquisition
$60,047 $3.58 p/Share
16,773 Added 30.34%
38,509 Voting Common Shares, ...
Jan 01 2021
BUY
Grant, award, or other acquisition
$63,741 $8.23 p/Share
7,745 Added 26.08%
21,947 Voting Common Shares, ...
JTP

James T. Parsons

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC